Bloom Science, Inc. is a biotechnology company focused on discovering, developing and commercializing live biotherapeutics to treat unmet neurological and inflammatory diseases. Bloom’s team of scientists, data-geeks and never-say-die entrepreneurs are rethinking how medicines are developed that can take advantage of our expanding insight into the role our gut microbiome plays in modulating key processes in the brain and immune system. Bloom has developed IrisRx, a best-in-class microbiome focused drug discovery platform, using a reverse translational approach of demonstrated clinical treatments into de-risked therapeutic opportunities utilizing rational selection and engineering of keystone human gut microbiota. For more information, please visit www.bloomscience.com